Russell Investments Group
INO icon

Russell Investments Group’s Inovio Pharmaceuticals INO Stock Holding History

Russell Investments Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,070
Closed -$4.21K – 4184
2025
Q2 		$4.21K Sell
2,070
-2,867
-58% -$5.49K ﹤0.01% 3485
2025
Q1 		$8.05K Buy
+4,937
New +$9.91K ﹤0.01% 3281
2024
Q4 		– Sell
-1,733
Closed -$10K – 3747
2024
Q3 		$10K Hold
1,733
– – ﹤0.01% 3078
2024
Q2 		$14K Hold
1,733
– – ﹤0.01% 3005
2024
Q1 		$24.1K Hold
1,733
– – ﹤0.01% 2757
2023
Q4 		$10.6K Hold
1,733
– – ﹤0.01% 2820
2023
Q3 		$8.09K Hold
1,733
– – ﹤0.01% 3055
2023
Q2 		$9.29K Hold
1,733
– – ﹤0.01% 2976
2023
Q1 		$17.1K Hold
1,733
– – ﹤0.01% 2833
2022
Q4 		$32.4K Hold
1,733
– – ﹤0.01% 2763
2022
Q3 		$35K Hold
1,733
– – ﹤0.01% 2769
2022
Q2 		$35K Hold
1,733
– – ﹤0.01% 2754
2022
Q1 		$74K Hold
1,733
– – ﹤0.01% 2600
2021
Q4 		$103K Hold
1,733
– – ﹤0.01% 2835
2021
Q3 		$148K Sell
1,733
-805
-32% -$80.8K ﹤0.01% 2825
2021
Q2 		$282K Hold
2,538
– – ﹤0.01% 2804
2021
Q1 		$282K Buy
2,538
+697
+38% +$91.7K ﹤0.01% 2739
2020
Q4 		$195K Sell
1,841
-805
-30% -$107K ﹤0.01% 2764
2020
Q3 		$367K Buy
2,646
+1,841
+229% +$384K ﹤0.01% 2532
2020
Q2 		$260K Buy
+805
New +$129K ﹤0.01% 2623
2018
Q1 		– Sell
-1,570
Closed -$78K – 2943
2017
Q4 		$78K Hold
1,570
– – ﹤0.01% 2818
2017
Q3 		$119K Sell
1,570
-3,432
-69% -$255K ﹤0.01% 2753
2017
Q2 		$471K Sell
5,002
-1,474
-23% -$126K ﹤0.01% 2436
2017
Q1 		$514K Sell
6,476
-248
-4% -$19.8K ﹤0.01% 2415
2016
Q4 		$559K Buy
+6,724
New +$608K ﹤0.01% 2425

Other funds holding INO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group's INO Position: Q3 2025 in Review

Russell Investments Group sold out of Inovio Pharmaceuticals (INO) in Q3 2025, closing a stake of 2,070 shares — an estimated $4.21K sold.

Russell Investments Group first reported a position in INO in Q4 2016 and held it in 25 quarters. The position peaked at $559K in Q4 2016. 99 funds tracked by Wall St. Rank hold INO as of Q3 2025.

  • Russell Investments Group reported no remaining Inovio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Russell Investments Group sold 2,070 Inovio Pharmaceuticals shares in Q3 2025, an estimated $4.21K.
  • Russell Investments Group first reported a position in Inovio Pharmaceuticals in Q4 2016 and held it in 25 quarters.
  • Russell Investments Group's Inovio Pharmaceuticals position peaked at $559K in Q4 2016.
  • 99 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2025.

Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.